{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:27:33Z","timestamp":1782952053014,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clnesp.2025.102898","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:35:37Z","timestamp":1768203337000},"page":"102898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes"],"prefix":"10.1016","volume":"72","author":[{"given":"Favour M.L.","family":"Foncha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6002-3883","authenticated-orcid":false,"given":"Joseph Y.","family":"Bena Nnang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.J.","family":"Fodop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Best C.I.","family":"Poudjoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri S.","family":"Tcheuko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel G.K.","family":"Mekontso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.102898_bib1","series-title":"UpToDate","article-title":"Pathophysiology of sickle cell disease topic","author":"Steinberg","year":"2025"},{"key":"10.1016\/j.clnesp.2025.102898_bib2","series-title":"UpToDate","article-title":"Acute vaso-occlusive pain management in sickle cell disease","author":"deBaun","year":"2025"},{"issue":"1_suppl","key":"10.1016\/j.clnesp.2025.102898_bib3","first-page":"30S","article-title":"Acquired amino acid deficiencies: a focus on arginine and glutamine","volume":"32","author":"Morris","year":"2017","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.102898_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2015-06-649491","article-title":"Revisiting the hyperhemolysis paradigm","volume":"126","author":"Gladwin","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clnesp.2025.102898_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1476-5381.1992.tb13413.x","article-title":"L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia","volume":"107","author":"Kawabata","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.102898_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0924-977X(91)90006-G","article-title":"Analgesic effect of L-arginine in patients with persistent pain","volume":"1","author":"Harima","year":"1991","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"10.1016\/j.clnesp.2025.102898_bib7","doi-asserted-by":"crossref","unstructured":"Morris C, Kuypers F, Lavrisha L, Ansari M, Sweeters N, Stewart M, et al. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica 2013;98(9):1375\u20131382. https:\/\/doi.org\/10.3324\/haematol.2013.086637.","DOI":"10.3324\/haematol.2013.086637"},{"issue":"4","key":"10.1016\/j.clnesp.2025.102898_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(18)30020-6","article-title":"Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-lind, random order crossover trial","volume":"5","author":"Cox","year":"2018","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102898_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1164\/rccm.202108-1930OC","article-title":"Arginine therapy and cardiopulmonary hemodynamics in hospitalized children with sickle cell anemia: a prospective, double-linded, randomized placebo-controlled clinical trial","volume":"206","author":"Onalo","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnesp.2025.102898_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s40272-025-00701-w","article-title":"Clinical study to evaluate the possible efficacy and safety of L-Arginine in children with sickle cell disease and increased tricuspid regurgitant jet velocity: a randomized controlled trial","author":"Gomaa","year":"2025","journal-title":"Paediatr Drugs"},{"issue":"7","key":"10.1016\/j.clnesp.2025.102898_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ajh.27692","article-title":"Arginine therapy for pain in sickle cell disease: a Phase-2 randomized, placebo-controlled trial","volume":"100","author":"Morris","year":"2025","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102898_bib12","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1002\/ajh.26396","article-title":"Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: a randomized placebo-controlled trial in progress","volume":"97","author":"Reyes","year":"2022","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102898_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.26028","article-title":"Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria","volume":"96","author":"Onalo","year":"2021","journal-title":"Am J Hematol"},{"issue":"SUPPL 1","key":"10.1016\/j.clnesp.2025.102898_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2020-134123","article-title":"Impact of oral arginine therapy on global arginine bioavailability in Nigerian children with sickle cell anemia and vaso-occlusive pain","volume":"136","author":"Onalo","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clnesp.2025.102898_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1167","article-title":"Effects of l -arginine supplementation in patients with sickle cell disease: a systematic review and meta-analysis of clinical trials","volume":"6","author":"Sadeghi","year":"2023","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.clnesp.2025.102898_bib16","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.5 (Updated August 2024). Cochrane; 2024. Available at: www.training.cochrane.org\/handbook."},{"key":"10.1016\/j.clnesp.2025.102898_bib17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clnesp.2025.102898_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clnesp.2025.102898_bib18","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2025.102898_bib19","unstructured":"Review Manager (RevMan). Version (8.13.0). The Cochrane Collaboration. Published online December 18, 2024. Available at revman.cochrane.org."},{"issue":"7","key":"10.1016\/j.clnesp.2025.102898_bib20","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"10.1016\/j.clnesp.2025.102898_bib21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.clnesp.2025.102898_bib23","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 6: choosing effect measures and computing estimates of effect","author":"Higgins","year":"2024"},{"key":"10.1016\/j.clnesp.2025.102898_bib24","series-title":"GRADEpro guideline development tool [software]","author":"GRADEpro","year":"2024"},{"key":"10.1016\/j.clnesp.2025.102898_bib25","series-title":"GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013","author":"Sch\u00fcnemann","year":"2013"},{"key":"10.1016\/j.clnesp.2025.102898_bib26","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 15: interpreting results and drawing conclusions","author":"Sch\u00fcnemann","year":"2024"},{"key":"10.1016\/j.clnesp.2025.102898_bib27","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","article-title":"Chapter 14: completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2024"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725032115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725032115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:57:13Z","timestamp":1774058233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725032115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S2405457725032115"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.102898","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.102898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102898"}}